Citius Oncology Stock Forecast

Buy or Hold candidate since Aug 04, 2026 Gain 11.74%

The Citius Oncology Inc. stock price fell by -2.06% on the last day (Monday, 10th Aug 2026) from $0.753 to $0.738. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 5.17% from a day low at $0.718 to a day high of $0.755. The price has been going up and down for this period, and there has been a 32.64% gain for the last 2 weeks. Volume has increased on the last day by 26 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 71 thousand shares were bought and sold for approximately $52.02 thousand.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $0.771 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -26.57% during the next 3 months and, with a 90% probability hold a price between $0.367 and $0.566 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

CTOR Signals & Forecast

The Citius Oncology Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.702 and $0.658. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, August 05, 2026, and so far it has fallen -6.05%. Further fall is indicated until a new bottom pivot has been found. Citius Oncology Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Citius Oncology Inc. stock

Citius Oncology Inc. finds support from accumulated volume at $0.709 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0371 between high and low, or 5.17%. For the last week, the stock has had daily average volatility of 14.45%.

Our recommended stop-loss: $0.704 (-4.52%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 3 days ago.)

Trading Expectations (CTOR) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Citius Oncology Inc. to open at $0.737, and during the day (based on 14 day Average True Range), to move between $0.703 and $0.772, which gives a possible trading interval of +/-$0.0687 (+/-9.77%) up or down from last closing price. If Citius Oncology Inc. takes out the full calculated possible swing range there will be an estimated 9.77% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.760 (3.05%) than the support at $0.709 (3.88%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Citius Oncology Inc. stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

Current score: 1.194 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $0.737 ( 0.0949%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk